Please note: The information displayed on this page might be outdated.
Angiocrine Bioscience: (Private) Developing technologies out of Weill Cornell focused on regeneration of lungs, tendons, cartilage, and liver as well as discovery programs for other tissue types. IND enabling/pre-clinical stage with existing data (some published in Nature and Cell). First generation programs are autologous genetically-modified products, designed for fast entry into clinic and commercialization with a proprietary manufacturing system. Second generation is allogeneic, ‘off-the-shelf’ and potentially universal regenerative products. Also possess an enabling technology for gene-therapy/gene-editing companies.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - Middle Atlantic
Clinical Stage
Pre-Clinical Stage
Disease Space
Hematology, Respiratory
Finance
Pre-Revenues
Industry
Biotechnology
Listing
Private
Market Cap
Private
Therapeutic Modalities
Cell Therapy, Gene Therapy
Website:
Address:
300 York Ave
New York, NY 10028
United States

Company Participants at Solebury Trout KOL Day

  • Paul Finnegan, CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.